About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials in Houston | 110 Studies

Clinical Trials LupusHouston

Lupus Clinical Trials in Houston

Find 110 clinical trials for lupus near Houston, Texas. Connect with research centers in your area.

All Lupus trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 110 trials

CompletedA Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)The purpose of this study is to assess the impact of belimumab on immune response to pneumococcal vaccine in subjects with Systemic Lupus Erythematosus (SLE).NCT01597492·Birmingham, Alabama and 14 others Active not recruitingA Study of Obexelimab in Patients With Systemic Lupus ErythematosusThis study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).NCT06559163·Peoria, Arizona and 109 others

PreviousPage 2 of 6Next

Lupus Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus ErythematosusThis parallel-group, double-blind, placebo-controlled study will evaluate the efficacy and safety of obinutuzumab versus placebo in participants with active, autoantibody-positive…NCT04963296·Anniston, Alabama and 63 others

CompletedLong-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus ErythematosusThe main objective of the trial is to characterize the long-term safety and tolerability of BMS-986165 in subjects with Systemic Lupus Erythematosus (SLE).NCT03920267·Birmingham, Alabama and 97 others

CompletedBelimumab Assessment of Safety in SLEThe purpose of this study is to further enhance the existing knowledge regarding the side effects of belimumab when given with other lupus medicines to adults with active systemic…NCT01705977·Anniston, Alabama and 249 others

Active not recruitingTwo-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune DiseaseThe purpose of this study is to demonstrate the comparability of ianalumab exposure following the sub-cutaneous (s.c.) administration of one injection of 300 mg/2 mL auto-injector…NCT06293365·Anniston, Alabama and 36 others

CompletedA Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus ErythematosusThis is a Phase II, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of rontalizumab compared with placebo in patients with…NCT00962832·Anniston, Alabama and 78 others

TerminatedA Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)The purpose of this study was to assess the efficacy and safety of zetomipzomib (30 mg or 60 mg) compared with placebo in achieving renal response after 52 weeks of treatment in…NCT05781750·Lake Charles, Louisiana and 49 others

CompletedStudy of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus ErythematosusThe primary objective of the study is to confirm the clinical efficacy of epratuzumab in the treatment of subjects with Systemic Lupus Erythematosus (SLE)NCT01262365·Birmingham, Alabama and 140 others

TerminatedCOVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersThis is a randomized, multi-site, adaptive, open-label clinical trial comparing the immune response to different additional doses of COVID-19 vaccine in participants with…NCT05000216·Los Angeles, California and 28 others

CompletedStudy to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)The primary purpose of the study is to evaluate the efficacy of BIIB059 (litifilimab) in reducing disease activity in participants with systemic lupus erythematosus (SLE) with…NCT02847598·Anniston, Alabama and 127 others

CompletedA Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus ErythematosusPrimary objective: To assess the efficacy and safety of different dose regimens of ALX-0061 administered subcutaneously (s.c.) to subjects with moderate to severe active…NCT02437890·Birmingham, Alabama and 117 others

CompletedStudy of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus NurtureOBJECTIVES: I. Continue yearly ascertainment visits of all patients of the established Lupus in Minority Populations: Nature vs Nurture (LUMINA) study cohort.NCT00006134·Birmingham, Alabama and 2 others

CompletedPEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus ErythematosusThe purpose of this study is to evaluate the efficacy, safety and tolerability of three different doses of A-623 administered in addition to standard therapy in subjects with…NCT01162681·Birmingham, Alabama and 73 others

Active not recruitingProgram to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus ErythematosusSystemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems.NCT05843643·Chandler, Arizona and 368 others

Active not recruitingA Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus ErythematosusThe goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to severe symptoms.NCT05672576·Tucson, Arizona and 146 others

Active not recruitingA Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusIn this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE).NCT04895241·Homewood, Alabama and 163 others

CompletedEfficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)The purpose of this study is to evaluate the efficacy, safety, and tolerability of belimumab in adult patients of black race with systemic lupus erythematosus (SLE; lupus).NCT01632241·Birmingham, Alabama and 95 others

CompletedActhar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active DiseaseThis Phase 4 study is being performed to examine the effects of Acthar for the indicated use of treatment of SLE.NCT01753401·Jonesboro, Arkansas and 21 others

CompletedA Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or MyositisThe objective of this study is to assess the safety and tolerability of sifalimumab in adult participants with active systemic lupus erythematosus (SLE) or active dermatomyositis…NCT00979654·Anniston, Alabama and 27 others

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia